超声造影检查失代偿期肝硬化门静脉血流动力学指标的变化

doi:10.3969/j.issn.1672-5069.2017.04.033

Abstract

Zhong Yue, Zhang Guansheng, Qiu Wei.. Hemodynamic parameters and ultrasonography imaging in patients with decompensated liver cirrhosis and portal hypertension[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2017, 20(4): 498-499.

References

[1] 杨卫生,郭武华. 肝硬化门静脉高压症患者肝脏血流动力学指标与门静脉压力的相关性研究. 中国全科医学,2016,19(23):2784-2788.
[2] 丰乃奇,曲俊朴,王雪瑞,等. 声脉冲辐射力成像联合肝固有动脉血流动力学评估肝硬化程度. 放射学实践,2016,31（9）:886-889.
[3] Masson S,Emmerson I,Henderson E,et al. Clinical but not histological factors predict long-term prognosis in patients with histologically advanced non-decompensated alcoholic liver disease. Liver Int,2014,34（2）:235-242.
[4] Ghaoui R,Friderici J,Visintainer P,et al. Measurement of the quality of care of patients admitted with decompensated cirrhosis. Liver Int,2014,34（2）:204-210.
[5] 陈中将,赵展. 超声门静脉血流动力学检测在老年肝硬化门静脉高压诊断中的意义. 中国老年学杂志,2016,36（3）:655-657.[6] 汤雯,贾继东. 肝硬化患者门静脉血栓形成的发病机制及诊断进展. 中华肝脏病杂志,2015,23（7）:550-552.
[7] 周玲莉,夏晓辉,沈冬花,等. 彩色多普勒超声在肝门静脉高压血流动力学的应用. 中国医学装备,2016,13（10）:44-48.
[8] 庄园,丁红,韩红,等. 超声造影评价失代偿期肝硬化患者门静脉高压的临床价值. 中华肝脏病杂志,2016,24（4）:270-274.
[9] Bird TG,Ramachran P,Thomson E,et al. Decompensated liver cirrhosis. Anaesthesia Intens Care Med,2015,16（4）:180-185.
[10] Harrison PM. Management of patients with decompensated cirrhosis. Clin Med,2015,15（2）:201-203.
[11] 张明,诸葛宇征,邹晓平,等. 肝静脉压力梯度与肝硬化患者临床特征的相关性. 中华消化杂志,2015,32（8）:530-533.
[12] 张海清,王兴华,聂宏娟,等. 超声造影评价肝纤维化血流灌注特征的初步研究. 中国中西医结合影像学杂志,2013,11（2）:146-148.
[13] 汤善宏,秦建平,蒋明德,等. 肝静脉压力梯度在门静脉高压相关疾病中应用的研究进展. 中华肝脏病杂志,2014,22（7）:555-557.
[14] 吴碧君,谢佳佳,周苏晋,等. 彩色多普勒超声诊断肝内门一体静脉分流价值探讨. 实用肝脏病杂志,2015,18（4）：391-394.
[15] Liu W,Zheng J,Xing R,et al. Clinical significance of a scoring formula of liver injury for the preoperative evaluation of patients with liver cirrhosis. Eur J Gastroenterol Hepatol,2014,26（1）:95-100.

Hemodynamic parameters and ultrasonography imaging in patients with decompensated liver cirrhosis and portal hypertension

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	Zhuang Ying, Lin Zhihui.. Clinical manifestations and diagnosis of portal vein thrombosis [J]. Journal of Practical Hepatology, 2019, 22(6): 765-767.
[2]	Yang Caiyong, Chen Na, Li Kui, et al.. Clinical significance of peripheral blood Treg and Th17 cells in patients with chronic hepatitis C and hepatitis C-induced liver cirrhosis [J]. Journal of Practical Hepatology, 2019, 22(6): 868-871.
[3]	Wu Dan Ma Xiangying.. Insulin resistance,carotid atherosclerosis and left ventricular function in patients with NAFLD-induced liver cirrhosis [J]. Journal of Practical Hepatology, 2019, 22(6): 876-879.
[4]	He Zhi’an, Yu Liping, Lai Jiangqiong, et al.. Evaluation of varices bleeding and portal vein thrombosis by ARFI in patients with cirrhosis and esophagogastric varices [J]. Journal of Practical Hepatology, 2019, 22(6): 888-891.
[5]	Wang Yueyuan, Wang Yan, Zhang Dandan. Short-term efficacy of terlipressin and octreotide combination in treatment of cirrhotic patients complicated by hepatorenal syndrome [J]. Journal of Practical Hepatology, 2019, 22(5): 684-687.
[6]	Zhang Mei, Shi Xiuying, Li Linjuan, et al. Hepatic expression of interferon inducible protein -10 in patients with hepatitis B liver cirrhosis and hepatogenic diabetes mellitus [J]. Journal of Practical Hepatology, 2019, 22(5): 688-691.
[7]	Dan Zhuyongji, Liu Zhilan, Lu Yanyan, et al. Efficacy of endoscopic sequential variceal 1igation plus sclerotherapy in treatment of patients with hepatitis B-induced liver cirrhosis complicated by esophageal gastric varices bleeding [J]. Journal of Practical Hepatology, 2019, 22(5): 692-695.
[8]	Huang Hanjun, Lu Fengrong, Zhang Can. Clinical value of MRI scanning based on exchange hemodynamics model in evaluating liver cirrhosis [J]. Journal of Practical Hepatology, 2019, 22(5): 696-699.
[9]	Zhao Fangfang, Zhai Yongzhen, Feng Guohe. Efficacy and safety of autologous peripheral blood stem cell transplantation in patients with hepatitis B cirrhosis [J]. Journal of Practical Hepatology, 2019, 22(5): 700-703.
[10]	Chen Shan, Zhuang Huashuai, Xing Yixi, et al. Preventive application of meropenem in patients with liver cirrhosis complicated by upper gastrointestinal bleeding [J]. Journal of Practical Hepatology, 2019, 22(5): 704-707.
[11]	Xu Qilin, Hao Shaohuan, Ran Bo. Risk factors of portal vein thrombosis after splenectomy in patients with liver cirrhosis and portal hypertension [J]. Journal of Practical Hepatology, 2019, 22(5): 708-711.
[12]	Jin Lianghong, Li Xingjie, Guan Hongbo, et al. Clinical value of dual-energy CT iodine quantification combined with dynamic contrast-enhanced MRI in evaluating hepatic hemodynamics and liver functions in patients with hepatitis B liver cirrhosis [J]. Journal of Practical Hepatology, 2019, 22(5): 712-715.
[13]	Bian Xinqu, Chen Jie, Liu Yanmin, et al. Serum thyroid hormone level changes in patients with primary biliary cholangitis receiving ursodeoxycholic acid therapy [J]. Journal of Practical Hepatology, 2019, 22(5): 716-719.
[14]	Xiao Han, Wang Li. Mechanisms of thrombocytopenia in liver cirrhosis [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(4): 462-465.
[15]	Han Meiling, Chen Ping. Antiviral therapy in patients with liver cirrhosis and thrombocytopenia [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(4): 466-469.